This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, Ireland, Lithuania, Netherlands, Romania, United Kingdom, United States, South Africa
The drug VIMOVO contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Naproxen
UNII 57Y76R9ATQ - NAPROXEN
|
|
Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. |
|
2
Esomeprazole
UNII R6DXU4WAY9 - ESOMEPRAZOLE MAGNESIUM
|
|
Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIMOVO Delayed release tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| M01AE52 | Naproxen and esomeprazole | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 542820040006917, 542820040007017 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02361701, 02361728 |
| Country: EE | Ravimiamet | Identifier(s): 1437768, 1437779, 1437780, 1437791, 1437803, 1437814, 1437825, 1460179 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 73182 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 431530 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 182339 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 23216 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1050688, 1050916, 1058591, 1058592, 1058593, 1058594, 1058595, 1058596, 1058597, 1058598, 1058599, 1058600, 1089161 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 95710 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68965001, W68965002, W68965003, W68965004, W68965005, W68965006, W68965007, W68965008, W68965009, W68965010, W68965011, W68965012, W68965013, W68965014, W68965015, W68965016, W68965017, W68965018, W68965019, W68965020, W68965021, W68965022, W68965023, W68965024, W68965025, W68965026, W68965027, W68965028, W68965029, W68965030, W68965031, W68965032, W68965033, W68965034 |
| Country: US | FDA, National Drug Code | Identifier(s): 75987-030, 75987-031 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 45/3.1/0179 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
